Related: Novo Nordisk Ignites High-Stakes Bidding War with Pfizer for Obesity Biotech Metsera Obesity-related chronic diseases (diabetes, cardiovascular disease, sleep apnea) remain a huge public health and cost burden in the US
This post walks through situations where GLP-1 medications may not be a good fit, or where careful medical and nutrition oversight is essential
Safety Considerations and Provider-Guided Eligibility for Perimenopausal Women GLP-1 medications are not suitable for all women in their 40s
Due to the increased T 1/2 and T lag after consumption of the oat bread compared with the wheat bread, one could expect a later peak in GLP-1 secretion after consumption of the oat bread, but no differences in the postprandial period were detected
Minich, T
How to safely switch between GLP-1 medications You can switch between GLP-1 medications if the GLP-1 you are currently taking is not showing significant results despite dosage adjustments, you are experiencing intolerable adverse effects, or you want to change dosing frequency (from weekly to daily or vice versa)